If funding is available, the state mental health department must set up a medical school pilot where eligible adults may receive therapy in federally approved research.
The state mental health department must set up a psychedelic therapy pilot through a Connecticut medical school, if funding is available. Eligible adults may receive MDMA- or psilocybin-assisted therapy as part of federally approved research.
The Department of Mental Health and Addiction Services must establish a psychedelic-assisted therapy pilot, administered by a medical school in Connecticut. Patients must be at least 18 and meet clinical eligibility criteria set by the selected medical school's review board. The criteria include, but are not limited to, Connecticut residents who are veterans, retired first responders, or direct care health care workers. The department must establish the program within available appropriations. The therapy must be part of a research program approved by the federal Food and Drug Administration. This section takes effect July 1, 2026; the enacted wording shown here states no end date.
No hearings or votes scheduled.